Quadruplexn ucleic acids are promising targets for cancert herapy.I nt his study we used af ragment-based approach to create new flexible G-quadruplex( G4) DNA-interactive small molecules with good calculated oral drug-like properties, based on quinoline and triazole heterocycles. G4 meltingt emperaturea nd polymerase chain reaction (PCR)-stopa ssays showedt hat two of these compoundsa re selective G4 ligands, as they were able to induce and stabilizeG 4s in ad ose-and DNA sequence-dependent manner.M olecular docking studies have suggested plausible quadruplex binding to both the Gquartet and groove, with the quinoline module playing the major role. Compounds were screened for cytotoxicity against four cancerc ell lines, where 4,4'-(4,4'-(1,3-phenylene)bis(1H-1,2,3-triazole-4,1-diyl))bis(1-methylquinolin-1-ium) (1d)s howed the greater activity.I mportantly,d ose-response curves show that 1d is cytotoxic in the human colon cancer HT-29 cell line enriched in cancer stem-like cells, as ubpopulation of cells implicated in chemoresistance. Overall,t his study identified a new smallm olecule as ap romisingl ead for the development of drugs targeting G4 in cancer stem cells.